公司資料
NEXGEL 股價、新聞與催化劑
- 股票代碼:
- NXGL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.38 USD (-33.54%)
收盤價
最後更新: 2026年8月17日
5.31M USD
市值
股價為何變動
Following the latest company update, “NEXGEL Reports Second Quarter 2026 Financial Results”, NXGL closed down 33.5% at $0.3755 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
公司概覽
業務概覽
NexGel is a hydrogel and wound-care company focused on advanced dressings and delivery materials. Its business is centered on materials science rather than therapeutics or classic biotech.
所在地與產業分類
NexGel is headquartered in the United States and listed on NASDAQ. It sits in medical materials and wound care rather than biotechnology.
商業模式特徵
The company depends on product adoption, distribution channels, and the ability to scale its hydrogel platform into healthcare and consumer applications. Investors focus on revenue growth, margin trends, and commercial execution.
生技產業定位
NexGel is outside biotech and belongs to the wound-care materials layer. Its stock is driven by product demand and execution, not clinical data.
未來催化劑
- NEXGEL’s catalysts are wound-care and medical-hydrogel product demand, along with any update that clarifies the commercial growth path. The market cares about recurring product usage.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。